Cross-Framework Mapping

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673)vsEU Clinical Trials Regulation (CTR 536/2014)

See exactly how 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls map to EU Clinical Trials Regulation (CTR 536/2014). Pre-computed mappings, identified gaps, and coverage analysis.

15
Controls Mapped
26
Gaps Found
27%
Coverage

According to the TheArtOfService Compliance Knowledge Graph:

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) maps to EU Clinical Trials Regulation (CTR 536/2014) with 27% coverage across 12 directly mapped controls. Analysis of 41 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls identifies 31 compliance gaps — primarily concentrated in General Provisions.

Source: TheArtOfService Knowledge Graph | 41 controls analysed | 693 frameworks | 819K+ cross-framework mappings

Control Mappings

Showing 15 of 15 mapped controls across 4 domains. Sign up to explore all 819K+ mappings across 693 frameworks.

Implementation(7 mappings)

Art. 12Data Ownership
CTR-X-01Data Protection Compliance
FATF-TR-IMP-03VASP AML/CFT
CTR-II-05Substantial Modification Procedure
ISO-8000-IMP-03Sector Applications3 targets
CTR-II-01Single Application via CTIS
CTR-II-02Part I Assessment (Scientific)
CTR-X-01Data Protection Compliance
PBD-IMP-01GDPR Article 25
CTR-X-01Data Protection Compliance
PBD-IMP-02Design Methodology
CTR-X-01Data Protection Compliance

General Provisions(5 mappings)

Art. 2Consent Definition
CTR-II-05Substantial Modification Procedure
Art. 4Participating Institutions
CTR-II-05Substantial Modification Procedure
JOR-1Scope and Definitions (Article 1–2)
CTR-X-01Data Protection Compliance
PY-2Definitions
CTR-X-01Data Protection Compliance
Part 1, Sec. 4Application and Scope
CTR-II-05Substantial Modification Procedure

Criminal Offences(1 mappings)

Art. 4Participating Institutions
CTR-II-05Substantial Modification Procedure

Liability of Legal Persons(2 mappings)

Art. 8Data Categories2 targets
CTR-II-05Substantial Modification Procedure
CTR-X-01Data Protection Compliance

Related Comparisons

Other 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) comparisons

Other EU Clinical Trials Regulation (CTR 536/2014) comparisons

Stop Paying Consultants to Read Spreadsheets

AI-powered compliance intelligence across 693 frameworks — at a fraction of consulting costs.

$0/forever

Free

  • 693 framework browser
  • Cross-framework mappings (819K+)
  • 824 compliance assessments
  • 3 AI queries & searches per day
Get Started Free
Recommended
$49/month

Professional

  • Unlimited AI Compliance Advisory
  • Unlimited full-text search
  • Framework self-assessment
  • PDF, Excel & CSV exports
Start 7-Day Free Trial →

What are the key differences between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and EU Clinical Trials Regulation (CTR 536/2014)?

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) has 41 controls across its framework, while EU Clinical Trials Regulation (CTR 536/2014) covers 17 controls. Direct mapping analysis identifies 12 overlapping controls (27% coverage). The frameworks diverge most significantly in General Provisions, where 13 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls have no direct EU Clinical Trials Regulation (CTR 536/2014) equivalent.

How many controls map between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and EU Clinical Trials Regulation (CTR 536/2014)?

Of 41 total 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls, 12 map directly to EU Clinical Trials Regulation (CTR 536/2014) controls — representing 27% coverage. The remaining 31 controls represent compliance gaps requiring additional documentation or compensating controls to satisfy both frameworks simultaneously.

What are the compliance gaps when mapping 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) to EU Clinical Trials Regulation (CTR 536/2014)?

31 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls have no direct equivalent in EU Clinical Trials Regulation (CTR 536/2014). The highest concentration of gaps is in General Provisions with 13 unmapped controls. These gaps represent areas where additional controls, policies, or documentation must be created to achieve compliance with both frameworks.

Which control domains have the most gaps between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and EU Clinical Trials Regulation (CTR 536/2014)?

The domain with the highest gap count is General Provisions (13 gaps). Export the full domain-by-domain gap breakdown via the Professional tier to generate a prioritised remediation roadmap.

This platform provides educational compliance tools, not legal, regulatory, or professional compliance advice. Cross-framework mappings are AI-assisted interpretations and do not reproduce or replace official standards. Framework names and trademarks belong to their respective owners. Consult qualified professionals for your specific compliance requirements. See our Terms of Service.